Can Crucell deliver for J&J;?; Medicago gets FDA OK for H1N1 study;

> With Dutch biotech Crucell about to be gobbled up by U.S. giant Johnson & Johnson, its chief executive Ronald Brus will need to deliver new vaccines quickly to make a success of the acquisition. Report

> Medicago has received FDA clearance for its Phase I H1N1 influenza VLP vaccine candidate clinical trial in the U.S. Medicago release

> Inovio Pharmaceuticals' new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines. Inovio release

Vaccine Market

> The BCG Vaccine Laboratory in Chennai, one of India's oldest vaccine manufacturing units, could soon become just a central drug testing lab. The Union health ministry had cancelled the manufacturing license of the company, housed in more than a century-old heritage building, Jan. 15, 2008, because it did not conform to the World Health Organization's good manufacturing protocol. News 

> Pevion Biotech today announced the appointment of Didier Hoch as Chairman of its Board of Directors. Until recently, Dr Hoch was President of Sanofi-Pasteur MSD, where he played a pivotal role in launching innovative vaccines, such as Gardasil, in Europe. Pevion release

> Vical has reported financial results for the year ended December 31, 2010. Vical had cash and investments of approximately $61 million at year-end 2010. The company received approximately $37 million of net proceeds from the sale of equity securities during 2010. Vical release